Skip to main navigation Skip to search Skip to main content

Intrauterine insemination as treatment for antisperm antibodies in the female

  • E. J. Margalloth
  • , E. Sauter
  • , R. A. Bronson
  • , D. L. Rosenfeld
  • , G. M. Scholl
  • , G. W. Cooper
  • Northwell Health System

Research output: Contribution to journalArticlepeer-review

44 Scopus citations

Abstract

Ninety-one women with long-standing infertility in the presence of humoral antisperm antibodies (ASA) underwent 473 cycles of intrauterine insemination of washed sperm (IUI), resulting in 26 pregnancies. Nine pregnancies were achieved in 67 women who underwent 285 IUI during unstimulated cycles (13% pregnancy rate; 3% pregnancy/cycles of treatment). Twenty women underwent 86 IUI after clomiphene citrate (CC) stimulation, resulting in 6 pregnancies (30%; 7% per cycle), while 28 underwent 102 cycles of IUI after human menopausal gonadotropins (hMG) stimulation, resulting in 11 pregnancies (39%; 11% per cycle). Twenty-one of the 26 pregnancies (81%) were achieved in the first 2 IUI cycles. During unstimulated and CC IUI cycles, all pregnancies occurred in the first two cycles of treatment, while with hMG stimulation pregnancies also occurred in the third, fourth, and fifth IUI cycles. Nine of these 91 women subsequently conceived spontaneously, and three others conceived through in vitro fertilization. Only 6 of the 38 pregnancies resulted in spontaneous abortion (16%). Thus, pregnancies achieved in women with ASA have no increased risk of abortion.

Original languageEnglish
Pages (from-to)441-446
Number of pages6
JournalFertility and Sterility
Volume50
Issue number3
DOIs
StatePublished - 1988

Fingerprint

Dive into the research topics of 'Intrauterine insemination as treatment for antisperm antibodies in the female'. Together they form a unique fingerprint.

Cite this